Vadim Le Joncour

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 9

Top Venues

Cancers

Journal of cellular and molecular medicine

EMBO molecular medicine

Biomaterials science

University of Helsinki/Academy of Finland

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Helsinki/Academy of Finland Sep 01 2019 - Aug 31 2022

Finland

Academy of Finland Postdoc Fellow :: CAN-Pro

Helsingin Yliopisto Aug 15 2015 - Aug 31 2019

Finland

Post-doctoral fellow :: Research Program Unit, Translational Cancer Biology

Université de Rouen Sep 01 2013 - Aug 01 2014

France

ATER-Temporary Lecturer and Research Assistant :: Faculté des Sciences et Techniques

Université de Rouen UFR des Sciences et Techniques Oct 01 2010 - Sep 01 2013

France

Doctorant-Ph.D. Student :: Inserm U982, Différenciation Neuronale et Neuroendocrine

Publications

Lennard Karsten, Nils Janson, Vadim Le Joncour, Sarfaraz Alam, Benjamin Müller, Jayendrakishore Tanjore Ramanathan, Pirjo Laakkonen, Norbert Sewald, Kristian M Müller
Bivalent EGFR-Targeting DARPin-MMAE Conjugates. International journal of molecular sciences 23 (5) (2022)
Neeraj Prabhakar, Joni Merisaari, Vadim Le Joncour, Markus Peurla, Didem Şen Karaman, Eudald Casals, Pirjo Laakkonen, Jukka Westermarck, Jessica M Rosenholm
Circumventing Drug Treatment? Intrinsic Lethal Effects of Polyethyleneimine (PEI)-Functionalized Nanoparticles on Glioblastoma Cells Cultured in Stem Cell Conditions. Cancers 13 (11) (2021)
Nicolò Tonali, Loreen Hericks, David C Schröder, Oliver Kracker, Radosław Krzemieniecki, Julia Kaffy, Vadim Le Joncour, Pirjo Laakkonen, Antoine Marion, Sandrine Ongeri, Veronica Isabel Dodero, Norbert Sewald
Peptidotriazolamers Inhibit Aβ(1-42) Oligomerization and Cross a Blood-Brain-Barrier Model. ChemPlusChem 86 (6) (2021)
Sandeep Kadekar, Ganesh N Nawale, Vignesh Kumar Rangasami, Vadim Le Joncour, Pirjo Laakkonen, Jöns Hilborn, Oommen P Varghese, Oommenp P Oommen
Redox responsive Pluronic micelle mediated delivery of functional siRNA: a modular nano-assembly for targeted delivery. Biomaterials science 9 (11) (2021)
Vadim Le Joncour, Pauliina Filppu, Maija Hyvönen, Minna Holopainen, S Pauliina Turunen, Harri Sihto, Isabel Burghardt, Heikki Joensuu, Olli Tynninen, Juha Jääskeläinen, Michael Weller, Kaisa Lehti, Reijo Käkelä, Pirjo Laakkonen
Vulnerability of invasive glioblastoma cells to lysosomal membrane destabilization. EMBO molecular medicine 11 (6) (2020)
Jayendrakishore Tanjore Ramanathan, Suvi Lehtipuro, Harri Sihto, József Tóvári, Lilla Reiniger, Vanda Téglási, Judit Moldvay, Matti Nykter, Hannu Haapasalo, Vadim Le Joncour, Pirjo Laakkonen
Prostate-specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain. Journal of cellular and molecular medicine 24 (12) (2020)
Johanna Eriksson, Vadim Le Joncour, Tiina Jahkola, Susanna Juteau, Pirjo Laakkonen, Olli Saksela, Erkki Hölttä
Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls. Molecular oncology 14 (4) (2020)
Vadim Le Joncour, Ana Martins, Maija Puhka, Jorma Isola, Marko Salmikangas, Pirjo Laakkonen, Heikki Joensuu, Mark Barok
A Novel Anti-HER2 Antibody-Drug Conjugate XMT-1522 for HER2-Positive Breast and Gastric Cancers Resistant to Trastuzumab Emtansine. Molecular cancer therapeutics 18 (10) (2019)
Eduard Figueras, Ana Martins, Adina Borbély, Vadim Le Joncour, Paola Cordella, Raffaella Perego, Daniela Modena, Paolo Pagani, Simone Esposito, Giulio Auciello, Marcel Frese, Paola Gallinari, Pirjo Laakkonen, Christian Steinkühler, Norbert Sewald
Octreotide Conjugates for Tumor Targeting and Imaging. Pharmaceutics 11 (5) (2019)

Vadim Le Joncour.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Vadim Le Joncour